Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,895	3,104	3,261	8,144	1,692	2,046
Market Cap Growth	152.03%	-4.84%	-59.96%	381.32%	-17.32%	-5.00%
Enterprise Value	6,981	4,110	3,952	8,399	1,846	1,920
Last Close Price	37.93	19.97	21.26	53.09	11.03	13.17
PE Ratio	-	-	-	-	-	47.36
PS Ratio	10.04	4.78	6.43	24.69	4.66	6.64
PB Ratio	-56.40	-126.49	7.88	13.59	2.34	2.66
P/TBV Ratio	-	-	15.00	14.43	2.50	2.83
P/FCF Ratio	88.67	189.81	-	-	-	-
P/OCF Ratio	50.58	21.95	-	-	48.11	22.56
EV/Sales Ratio	11.89	6.33	7.80	25.46	5.08	6.23
EV/EBITDA Ratio	-	-	-	-	92.74	27.58
EV/EBIT Ratio	-	-	-	-	-	49.02
EV/FCF Ratio	105.01	251.38	-	-	-	-
Debt / Equity Ratio	-10.48	-41.58	2.62	0.66	0.45	0.11
Debt / EBITDA Ratio	-	-	-	-	16.07	1.18
Debt / FCF Ratio	16.47	62.40	-	-	-	-
Asset Turnover	0.38	0.38	0.32	0.26	0.33	0.31
Inventory Turnover	5.58	5.08	4.21	5.08	5.43	4.19
Quick Ratio	0.06	0.10	0.29	0.18	0.42	1.94
Current Ratio	0.14	0.17	0.51	1.04	0.58	2.40
Return on Equity (ROE)	-480.66%	-228.96%	-43.93%	-18.57%	-3.55%	5.55%
Return on Assets (ROA)	-6.64%	-7.62%	-7.49%	-5.84%	-0.78%	2.47%
Return on Invested Capital (ROIC)	-17.49%	-17.66%	-16.08%	-12.18%	-1.74%	6.20%
Return on Capital Employed (ROCE)	-156.20%	-84.70%	-18.60%	-15.50%	-1.60%	4.60%
Earnings Yield	-6.28%	-14.33%	-6.80%	-1.50%	-1.54%	2.11%
FCF Yield	1.13%	0.53%	-19.97%	-1.80%	-19.03%	-7.97%
Dividend Yield	-	-	-	-	-	1.06%
Payout Ratio	-	-	-	-	-	54.64%
Buyback Yield / Dilution	-0.34%	-0.98%	0.20%	-0.75%	0.72%	-0.23%
Total Shareholder Return	-0.34%	-0.98%	0.20%	-0.75%	0.72%	0.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.